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ABSTRACT
Objective: The objective of this study was to evaluate the anti-inflammatory and antiarthritic potential of Parmelia perlata.
Methods: The relative study is based on in vitro anti-inflammatory and antiarthritic activity using hydroalcoholic extract of P. perlata (HAEPP). The 
preliminary phytochemical tests showed the presence of various phytochemical compounds such as alkaloids, flavonoids, and glycosides since the 
lichen species of P. perlata has the folklore claim of anti-inflammatory activity, thus it was studied by human red blood cells membrane stabilization 
method, and arthritic activity was carried using protein denaturation method using diclofenac as a standard.
Results: The results showed eminent anti-inflammatory and antiarthritic activity in a dose-dependent manner. The membrane stabilization showed 
the maximum effect at 78.54% at the concentration of 1000 µg/, and the protein denaturation was also found maximum at 1000 µg/ml concentration 
at 79.43%. Thus, our research states the potent anti-inflammatory activity and antiarthritic effect in P. perlata.
Conclusion: The HEAPP has a potent anti-inflammatory activity and antiarthritic activity. A further study has to be conducted to establish the 
pharmacological evidence behind the compound and the mechanism of action of the HAEPP on the inhibition of the inflammation process.
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INTRODUCTION
Inflammation is the reaction in living tissues caused due to injury, 
infection, or irritation which causes a complex array of enzyme 
activation or mediator release or fluid extravasations, cell migration, 
tissues breakdown, and repair, which are aimed to host defense and 
mostly activated in disease condition. Inflammation releases the 
lysosomal enzyme which produces a variety of disorders, leading 
to the tissue injury by damaging the macromolecule and lipid 
peroxidation of membrane [1,2]. The mechanism of inflammation is 
attributed in part to release of reactive oxygen species (ROS) from 
activated neutrophils and macrophages. Free radicals are important 
mediators that prove or sustain inflammatory process, and radical 
scavengers can attenuate the inflammation [3]. In addition, ROS 
propagate inflammation by stimulating the release of cytokines 
such as interleukins-1 (ILs-1), tumor necrosis factor-α (TNF-α), and 
interferon-γ, which stimulate recruitment of additional neutrophils 
and macrophages [4]. Prolonged inflammation leads to rheumatoid 
arthritis, hay fever, and atherosclerosis and also the development 
of infectious disease such as leprosy, tuberculosis, syphilis, 
asthma, inflammatory bowel disease, and autoimmune disease [5]. 
Rheumatoid arthritis is a chronic inflammatory disease of joints that 
result in joint pain swelling and destruction. It affects an estimated 
1% of adult population throughout the world [7]. It is an autoimmune 
disorder characterized by synovial proliferation, inflammation, and 
subsequent destruction such as deformity of joints or destruction 
of cartilage and bone [6]. The various mediators involved in the 
process include receptor activator of NF-KB (RANK) ligand and its 
receptor RANK, pro-inflammatory cytokines, for example, TNF-α, IL-
1, IL-6, IL-17, and IL-18 and matrix-degrading enzyme, for example, 
matrix metalloproteases and cathepsin K [9]. The pathophysiology 
of exaggerated synovial tissues involves hyperplasia and subintimal 
infiltration of T and B lymphocyte; this results in pannus tissues that 
irreversibly destroy the cartilage and bone in the affected joints. 
Polymorphonuclear leukocytes and macrophages are also stimulated 
which result in the production of inflammatory mediators including 
large amount of superoxide and hydrogen peroxide that can cause 
significant impairment and destruction of synovial fluid, cartilage, 
and other articular constituents [8].
As of now, there are four sorts of medication recommended for the 
treatment of rheumatoid joint pain which are Non-steroidal anti-
inflammatory drugs (NSAIDs) e.g.: diclofenac, ibuprofen., Steroidal 
hormones e.g. prednisone, dexamethasone. Disease modifying anti-
rheumatic drugs (DMARDs) e.g.: methotrexate, hydroxychloroquine, 
immunosuppressant (e.g.: azathioprine, cyclosporine) [10].
Parmelia perlata (Huds.) Ach. is a perennial lichen species belonging 
to family Parmeliaceae. They are found on the rocks or dead wood and 
also cultivated in temperate Himalayas and Kashmir hills. They are 
commonly known as Patthar phool, Kalpashee, Chhadila, Stone flower, 
Dagad phool, and Charela [11]. In traditional medicine, it was used for the 
treatment of edema, arthritis, for counteracting poisons, toxicosis, fever, 
obesity, eczema, cardiac tonic, refrigerant, and gout. The folklore claim 
states it to have the activity for the treatment of dyspepsia, diarrhea, 
dysentery, antiulcer, spermatorrhea, amenorrhea, astringent, diuretic, 
and also in promoting wound healing [12,13]. The early investigation 
resulted in the isolation of various chemicals such as parmelanostene, 
parmelabdone, tridecyl myristate, 3-ketooleanane, icosan-1-ol, and usnic 
acid. [14,15]. It has been reported to possess antioxidant, hypolipidemic 
and cytotoxic potential [16], antibacterial [17], hepatoprotective [18], 
antimicrobial [19,20], antidiabetic [21], antiulcer [22], and antiviral 
activity [23]. The objective of the study was to establish the potential of 
P. perlata for the anti-inflammatory and antiarthritic activity.
METHODS
The lichens species of P. perlata was collected from local herbal 
market in Chennai. It was authenticated by Professor P Jayaraman 
of Plant Anatomy Research Centre (PARC), Herbal PARC unit, 
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Tambaram, Chennai. The authentication number on the certificate is 
PARC/2016/3228.
Extraction
The dried P. perlata was coarsely grounded and was defatted using 
petroleum ether and successive extraction was done using 70% alcohol 
by maceration process for 72 h at room temperature with intermittent 
shaking. The extract was concentrated under reduced pressure and 
concentrated. The extract was kept in air-tight container and stored in 
cool temperature [24,25].
Preliminary phytochemical analysis
A small quantity of the powdered lichen was subjected to phytochemical 
tests using established chemical procedure. Standard procedures for 
the determination of alkaloids, tannins, saponins, glycosides, flavonoids, 
carbohydrates, fats and oil was performed and reported.
THE IN VITRO ANTI-INFLAMMATORY ACTIVITY
Human RBC membrane stabilization method
The in vitro anti-inflammatory activity of hydroalcoholic extract of 
P. perlata (HAEPP) extract of P. perlata was evaluated by human red 
blood cell membrane stabilization method. The blood was collected 
from healthy human volunteer who had not taken any NSAIDS for 
2 weeks before the experiment, and the blood was mixed with equal 
volume of Alsever solution (2% dextrose, 0.8% sodium citrate, 0.5% 
citric acid, and 0.42% NaCl) and centrifuged at 3000 rpm. The packed 
cells were washed with isosaline and a 10% suspension was made. 
Various concentrations of extracts were prepared, namely 50, 100, 250, 
500, and 1000 mcg/ml using distilled water and to each concentration 
of 1 ml of phosphate buffer, 2 ml hyposaline, and 0.5 ml of human red 
blood cells (HRBC) suspension were added. It is incubated at 37°C 
for 30 min and centrifuged at 3000 rpm for 20 min. The hemoglobin 
content of the supernatant solution was estimated using UV-visible 
spectrophotometer at 560 nm. The diclofenac sodium was used as 
standard.
THE IN VITRO ANTIARTHRITIC ACTIVITY
Egg albumin denaturation method
The reaction mixture (5 mL) consisted of 0.2 mL of egg albumin (from 
fresh hen’s egg), 2.8 ml of phosphate-buffered saline (PBS, pH6.4), and 
2 ml of varying concentrations (50, 100, 250, 500, and 1000 µg/ml) of 
drug. A similar volume of double-distilled water served as the control. 
Next, the mixtures were incubated at 37°C ± 2°C in a BOD incubator for 
15 min and then heated at 70°C for 5 min. After cooling, the absorbance 
was measured at 660 nm using the vehicle as a blank. Diclofenac 
sodium in the concentrations of 50, 100, 250, 500, and 1000 µg/mL was 
used as the reference drug and treated similarly for the determination 
of absorbance.




Vt=Absorbance of the test sample,
Vc=Absorbance of control.
Statistical analysis
All data were presented as the mean ± standard deviation. Statistical 
analysis was performed by one-way analysis of variance to evaluate 
significant differences between groups using GraphPad Prism 5 
(GraphPad Software Inc., La Jolla, CA, USA). p<0.05 was considered 
statistically significant.
RESULTS
HRBC membrane stabilization method
The HAEPP showed anti-inflammatory activity (Fig. 1) by inhibiting the 
hemolysis of HRBC. The HEAPP and diclofenac response were on dose 
concentration as preparation showed the increase in activity as the 
concentration of the solution increased from 50 µg to 1000 µg/ml. The 
minimum activity was seen at 50 µg as 34.6% and 30.87%, respectively, 
and as the dose was increased to 100 µg, the activity was 47.33%. The 
250 µg concentration showed the activity as 65.22% and the 500 µg 
concentration had 79.86% response. The maximum activity was seen 
at 1000 µg as it inhibited the 96.25% and 87.70, respectively, of the 
hemolysis.
Egg protein denaturation method
The HAEPP showed antiarthritic (Fig. 2) activity by inhibiting the 
protein denaturation. The minimum activity was seen as 35.14% at 
50 µg concentration for HAEPP and 31.68% for diclofenac. At 100 µg 
concentration, the response was seen as 47.58%, and at 250 µg 
concentration, the response was 67.25%. 78.14% activity was seen at 
500 µg concentration. The maximum activity for 1000 µg was seen as 
94.20% and 89.66%, respectively, for both HAEPP and diclofenac.
DISCUSSION
The in vitro anti-inflammatory activity has been studied using the HRBC 
membrane stabilization method as the erythrocyte membrane and 
lysosomal membrane are analogous and stabilization of erythrocyte 
implies that the HAEPP extract may well stabilize lysosomal membranes 
as it is important in limiting the inflammatory response by preventing 
the release of lysosomal constituents of activated neutrophil, such as 
proteases and bacterial enzymes, which further causes inflammation of 
tissues and damage on extracellular release. The extracellular activity 
of these enzymes is noted to be associated with acute or chronic 
inflammation. The nonsteroidal drugs act either by inhibiting these 
Fig. 2: Anti-arthritic activity using egg protein denaturation method
Fig. 1: Anti-inflammatory activity using HRBC membrane 
stabilisation method
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lysosomal enzymes or by stabilizing the lysosomal membrane [26].
Rheumatoid arthritis is the most common of autoimmune diseases 
which is prominently manifested by the inflammation and joint pain. 
There has been large number of mortality and morbidity associated 
with RA and thereby it has left substantial socioeconomic impact. The 
currently synthetic drugs are mainly used for symptomatic relief and 
side effect associated [27].
Thus, it has become essential to find an alternative method for the 
treatment of arthritis, thus resulting in the use of CAM therapies for 
the treatment of arthritis. The current researches are focused on the 
identification and isolation of active principle(s) from crude extracts 
of known medicinal plants/herbs, it’s to be overlooked that the strong 
synergism of several constituents in the crude drug may prove more 
potent and effective than any single purified compound, and this may 
also help to nullify the toxic effects of individual constituents [28].
CONCLUSION
The P. perlata, a potent unexplored lichen species, claimed to have an 
anti-inflammatory activity showed the significant response using in vitro 
model of HRBC membrane stabilization method for anti-inflammatory 
activity. The response increased gradually as the dose potentiated. 
The antiarthritic activity was also studied based on the results of the 
inflammatory action because the prolonged phase of inflammation 
leads to arthritis in bones and tendons. The antiarthritic activity was 
also eminent in the protein denaturation method. Thus, stating HEAPP 
has a potent anti-inflammatory activity and antiarthritic activity. 
A further study has to be conducted to establish the pharmacological 
evidence behind the compound and the mechanism of action of the 
HAEPP on the inhibition of inflammation process.
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